vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and WATTS WATER TECHNOLOGIES INC (WTS). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $625.1M, roughly 1.3× WATTS WATER TECHNOLOGIES INC). WATTS WATER TECHNOLOGIES INC runs the higher net margin — 13.4% vs 0.5%, a 12.9% gap on every dollar of revenue. On growth, WATTS WATER TECHNOLOGIES INC posted the faster year-over-year revenue change (15.7% vs 7.5%). Over the past eight quarters, WATTS WATER TECHNOLOGIES INC's revenue compounded faster (4.6% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
AERCO International, Inc. is a manufacturer and supplier of commercial condensing boilers, high efficiency water heating equipment and energy recovery systems in the HVAC/plumbing industry across a variety of markets including education, lodging, government, office buildings, healthcare, industrial and multifamily housing. In 1949, AERCO introduced the industry's first semi-instantaneous, tankless steam-to-water water heater. In 1988, AERCO introduced the first condensing and fully modulating...
ACHC vs WTS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $625.1M |
| Net Profit | $4.5M | $83.7M |
| Gross Margin | — | 49.5% |
| Operating Margin | — | 18.2% |
| Net Margin | 0.5% | 13.4% |
| Revenue YoY | 7.5% | 15.7% |
| Net Profit YoY | -50.8% | 24.0% |
| EPS (diluted) | $0.05 | $2.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $625.1M | ||
| Q3 25 | $851.6M | $611.7M | ||
| Q2 25 | $869.2M | $643.7M | ||
| Q1 25 | $770.5M | $558.0M | ||
| Q4 24 | $774.2M | $540.4M | ||
| Q3 24 | $815.6M | $543.6M | ||
| Q2 24 | $796.0M | $597.3M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $83.7M | ||
| Q3 25 | $36.2M | $82.2M | ||
| Q2 25 | $30.1M | $100.9M | ||
| Q1 25 | $8.4M | $74.0M | ||
| Q4 24 | $32.6M | $67.5M | ||
| Q3 24 | $68.1M | $69.1M | ||
| Q2 24 | $78.5M | $82.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 49.5% | ||
| Q3 25 | — | 48.8% | ||
| Q2 25 | — | 50.6% | ||
| Q1 25 | — | 48.8% | ||
| Q4 24 | — | 46.7% | ||
| Q3 24 | — | 47.3% | ||
| Q2 24 | — | 47.7% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 18.2% | ||
| Q3 25 | 4.7% | 18.2% | ||
| Q2 25 | 5.8% | 21.0% | ||
| Q1 25 | 1.7% | 15.7% | ||
| Q4 24 | 4.9% | 16.5% | ||
| Q3 24 | 12.1% | 17.1% | ||
| Q2 24 | 13.4% | 18.7% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 13.4% | ||
| Q3 25 | 4.3% | 13.4% | ||
| Q2 25 | 3.5% | 15.7% | ||
| Q1 25 | 1.1% | 13.3% | ||
| Q4 24 | 4.2% | 12.5% | ||
| Q3 24 | 8.4% | 12.7% | ||
| Q2 24 | 9.9% | 13.7% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $2.50 | ||
| Q3 25 | $0.40 | $2.45 | ||
| Q2 25 | $0.33 | $3.01 | ||
| Q1 25 | $0.09 | $2.21 | ||
| Q4 24 | $0.36 | $2.02 | ||
| Q3 24 | $0.74 | $2.06 | ||
| Q2 24 | $0.85 | $2.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $405.5M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $2.0B |
| Total Assets | $5.5B | $2.9B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $405.5M | ||
| Q3 25 | $118.7M | $457.7M | ||
| Q2 25 | $131.4M | $369.3M | ||
| Q1 25 | $91.2M | $336.8M | ||
| Q4 24 | $76.3M | $386.9M | ||
| Q3 24 | $82.1M | $303.9M | ||
| Q2 24 | $77.2M | $279.4M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.0B | ||
| Q3 25 | $3.1B | $2.0B | ||
| Q2 25 | $3.1B | $1.9B | ||
| Q1 25 | $3.0B | $1.8B | ||
| Q4 24 | $3.1B | $1.7B | ||
| Q3 24 | $3.0B | $1.7B | ||
| Q2 24 | $3.0B | $1.6B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $2.9B | ||
| Q3 25 | $6.4B | $2.7B | ||
| Q2 25 | $6.3B | $2.6B | ||
| Q1 25 | $6.1B | $2.5B | ||
| Q4 24 | $6.0B | $2.4B | ||
| Q3 24 | $5.9B | $2.4B | ||
| Q2 24 | $5.7B | $2.4B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $154.7M |
| Free Cash FlowOCF − Capex | — | $140.3M |
| FCF MarginFCF / Revenue | — | 22.4% |
| Capex IntensityCapex / Revenue | — | 2.3% |
| Cash ConversionOCF / Net Profit | 13.78× | 1.85× |
| TTM Free Cash FlowTrailing 4 quarters | — | $356.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $154.7M | ||
| Q3 25 | $73.2M | $122.4M | ||
| Q2 25 | $133.5M | $69.7M | ||
| Q1 25 | $11.5M | $55.2M | ||
| Q4 24 | $116.7M | $139.5M | ||
| Q3 24 | $163.1M | $90.7M | ||
| Q2 24 | $171.1M | $85.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $140.3M | ||
| Q3 25 | $-63.0M | $110.9M | ||
| Q2 25 | $-34.2M | $59.5M | ||
| Q1 25 | $-163.2M | $45.6M | ||
| Q4 24 | $-86.8M | $127.5M | ||
| Q3 24 | $-27.1M | $84.3M | ||
| Q2 24 | $16.9M | $78.5M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 22.4% | ||
| Q3 25 | -7.4% | 18.1% | ||
| Q2 25 | -3.9% | 9.2% | ||
| Q1 25 | -21.2% | 8.2% | ||
| Q4 24 | -11.2% | 23.6% | ||
| Q3 24 | -3.3% | 15.5% | ||
| Q2 24 | 2.1% | 13.1% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 2.3% | ||
| Q3 25 | 16.0% | 1.9% | ||
| Q2 25 | 19.3% | 1.6% | ||
| Q1 25 | 22.7% | 1.7% | ||
| Q4 24 | 26.3% | 2.2% | ||
| Q3 24 | 23.3% | 1.2% | ||
| Q2 24 | 19.4% | 1.1% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.85× | ||
| Q3 25 | 2.02× | 1.49× | ||
| Q2 25 | 4.43× | 0.69× | ||
| Q1 25 | 1.37× | 0.75× | ||
| Q4 24 | 3.58× | 2.07× | ||
| Q3 24 | 2.39× | 1.31× | ||
| Q2 24 | 2.18× | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
WTS
Segment breakdown not available.
